Fig. 1
From: Myocyte enhancer factor 2D provides a cross-talk between chronic inflammation and lung cancer
Expressions of MEF2 family genes in patients with lung cancer. The expression of MEF2s in patients with non-small-cell lung carcinoma (NSCLC) (a), large-cell carcinoma (LCC) (b), small-cell lung carcinoma (SCLC) (c). **p < 0.01, and ***p < 0.001, as compared with genes in non-cancer tissues. The expression of MEF2D in smokers, COPD patients, NSCLC patients, and COPD patients coexisting NSCLC (d). *p < 0.05, and ***p < 0.001, as compared with genes in healthy non-smokers